Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 8.
Article
Arends, Samuel;
Drenthen, Judith;
van den Bergh, Peter;
Franssen, Hessel;
Hadden, Robert DM;
Islam, Badrul;
Kuwabara, Satoshi;
... Cornblath, David R; + view all
(2022)
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.
Clinical Neurophysiology
, 138
pp. 231-240.
10.1016/j.clinph.2021.12.014.
|
|
Doets, Alex Y;
Walgaard, Christa;
Lingsma, Hester F;
Islam, Badrul;
Papri, Nowshin;
Yamagishi, Yuko;
Kusunoki, Susumu;
... Jacobs, Bart C; + view all
(2022)
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score.
Annals of Neurology
, 91
(4)
pp. 521-531.
10.1002/ana.26312.
|
|
Hughes, Richard AC;
(2024)
Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions.
European Journal of Neurology
, 31
(11)
, Article e16346. 10.1111/ene.16346.
|
|
Leonhard, SE;
Mandarakas, MR;
Gondim, FDAA;
Bateman, K;
Ferreira, MLB;
Cornblath, DR;
Van doorn, PA;
... Jacobs, BC; + view all
(2021)
Diagnosis and management of Guillain–Barré syndrome in ten steps.
Nature Reviews Neurology
, 81
(5)
pp. 817-836.
10.1038/s41582-019-0250-9.
|
|
Lunn, MP;
Cornblath, DR;
Jacobs, BC;
Querol, L;
Van Doorn, PA;
Hughes, RA;
Willison, HJ;
(2021)
COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations.
Brain
, 144
(2)
pp. 357-360.
10.1093/brain/awaa444.
|
|
Lunn, M;
(2021)
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study.
Journal of Neurology, Neurosurgery, and Psychiatry
10.1136/jnnp-2020-325815.
(In press).
|
 |
|
Manganelli, F;
Pisciotta, C;
Reilly, MM;
Tozza, S;
Schenone, A;
Fabrizi, GM;
Cavallaro, T;
... Santoro, L; + view all
(2016)
Nerve conduction velocity in CMT1A: what else can we tell?
European Journal of Neurology
, 23
(10)
pp. 1566-1571.
10.1111/ene.13079.
|
|
|
Querol, Luis;
Lewis, Richard A;
Hartung, Hans-Peter;
Van Doorn, Pieter A;
Wallstroem, Erik;
Luo, Xiaodong;
Alonso-Alonso, Miguel;
... Hughes, Richard AC; + view all
(2023)
An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.
Journal of the Peripheral Nervous System
, 28
(2)
pp. 276-285.
10.1111/jns.12551.
|
